非佐奈坦 Fezolinetant
非佐奈坦 Fezolinetant
【化學(xué)名】Fezolinetant
【原研】Euroscreen
【上市時(shí)間】2023年5月12日
【用途】用于治療血管舒縮癥和熱潮紅。
【劑型/規(guī)格】口服片劑,45 mg
非佐奈坦Fezolinetant
一、產(chǎn)品概述
Fezolinetant是由Euroscreen研發(fā)的一種小分子藥物,是一種NK3R拮抗劑。于2023年05月12日獲得美國食品藥品管理局FDA批準(zhǔn),用于治療血管舒縮癥和熱潮紅。
二、主要產(chǎn)品
Description | Structural Formula | CAS No. | Category |
Fezolinetant | 1629229-37-3 | API | |
(R)-4-(2,4-dimethoxybenzyl)-3-methylpiperazin-2-one | 1383146-20-0 | intermediates | |
tert-butyl (R)-2-methyl-3-oxopiperazine-1-carboxylate | 1629229-82-8 | intermediates | |
3-methyl-1,2,4-thiadiazole-5-carbohydrazide | 1375066-73-1 | intermediates | |
4-fluorobenzoic acid | 456-22-4 | intermediates |
Note: Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement and its liability is at buyer's risk.